The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Open-label, phase 2 study of roxadustat for treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies.
 
John A. Glaspy
No Relationships to Disclose
 
Nashat Y Gabrail
Honoraria - Dova Pharmaceuticals; GlaxoSmithKline; Pharmacosmos
Consulting or Advisory Role - Cardinal Health; ClinChoice; Dova Pharmaceuticals; Pharmacosmos
Speakers' Bureau - Dova Pharmaceuticals; GlaxoSmithKline; Pharmacosmos
 
Patricia A. Locantore-Ford
Consulting or Advisory Role - American Regent; Cardinal Health; Kite, a Gilead Company
 
Gopal C Saha
Employment - Apollomics; FibroGen
Stock and Other Ownership Interests - Apollomics; FibroGen
 
Elise Hardy
Employment - AstraZeneca
 
Tyson Lee
Employment - FibroGen
Stock and Other Ownership Interests - FibroGen
Research Funding - FibroGen
 
Katharina Modelska
Employment - FibroGen; Pfizer
Leadership - FibroGen; Pfizer
Stock and Other Ownership Interests - FibroGen
Honoraria - FibroGen
Research Funding - FibroGen
 
David H. Henry
Honoraria - AMAG Pharmaceuticals; Amgen
Consulting or Advisory Role - AMAG Pharmaceuticals; Amgen
Research Funding - Amgen
Travel, Accommodations, Expenses - AMAG Pharmaceuticals; Amgen